Stock listing
ADPT Stock Price, News, Filings & Events — Adaptive Biotechnologies Corporation
Selected listing: ADPT · NASDAQ · USD · US
This page tracks Adaptive Biotechnologies Corporation's ADPT:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ADPT:NASDAQ. ADPT:NASDAQ is the stock-level entry point for investors researching Adaptive Biotechnologies Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Adaptive Biotechnologies Corporation, trading under the ticker ADPT, is a public company based in the United States with a market capitalization of approximately $3.67 billion. The company specializes in utilizing its proprietary technology to analyze the immune system and develop diagnostic tools and therapies. Adaptive Biotechnologies focuses on advancing precision medicine through its innovative...
- Ticker
- ADPT:NASDAQ
- Asset type
- Stock
- Market cap
- $4.02B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Adaptive Biotechnologies Corporation ADPT:NASDAQ stock context
This page tracks Adaptive Biotechnologies Corporation's ADPT:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ADPT:NASDAQ. ADPT:NASDAQ is the stock-level entry point for investors researching Adaptive Biotechnologies Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Adaptive Biotechnologies Corporation, trading under the ticker ADPT, is a public company based in the United States with a market capitalization of approximately $3.67 billion. The company specializes in utilizing its proprietary technology to analyze the immune system and develop diagnostic tools and therapies. Adaptive Biotechnologies focuses on advancing precision medicine through its innovative...
Latest news from Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Reports Second Quarter 2026 Financial Results
July 29, 2026
Adaptive Biotechnologies to Report Second Quarter 2026 Financial Results on July 29, 2026
July 9, 2026
Adaptive Biotechnologies : Imviva Biotech Receives FDA IDE Authorization for clonoSEQ® Assay in TENACITY-01 Clinical Trial
June 30, 2026
Adaptive Biotechnologies Corporation Prices Upsized $300 Million Convertible Senior Notes Offering
June 17, 2026
Adaptive Biotechnologies Announces Plan to Separate Its MRD and Immune Medicine Businesses
June 15, 2026
Adaptive Biotechnologies Corporation earnings calls
Adaptive Biotechnologies Corporation (ADPT) Q2 2026 Earnings Call
July 29, 2026 · Replay with transcript and chapters
Adaptive Biotechnologies Corporation (ADPT) Q1 2026 Earnings Call
May 5, 2026 · Replay with transcript and chapters
Adaptive Biotechnologies Corporation (ADPT) Q4 2025 Earnings Call
February 5, 2026 · Replay with transcript and chapters
Adaptive Biotechnologies Corporation (ADPT) Q3 2025 Earnings Call
November 5, 2025 · Replay with transcript and chapters
Adaptive Biotechnologies Corporation (ADPT) Q2 2025 Earnings Call
August 5, 2025 · Replay with transcript and chapters
Adaptive Biotechnologies Corporation (ADPT) Q1 2025 Earnings Call
May 1, 2025 · Replay with transcript and chapters
Research Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corporation investor report
Review AI stock analysis and investor report context for ADPT:NASDAQ.
Adaptive Biotechnologies Corporation company profile
View the public company page for Adaptive Biotechnologies Corporation on 6ix.
Adaptive Biotechnologies Corporation news
Read company news and market updates connected to Adaptive Biotechnologies Corporation.
Adaptive Biotechnologies Corporation investor events
Find investor webinars, events, and replay context for Adaptive Biotechnologies Corporation.
Alternate listings
1HM:GETTEX
DE · EUR
Alternate listing for Adaptive Biotechnologies Corporation; the primary context on this page is ADPT:NASDAQ.
A2PLR5:LSX
DE · EUR
Alternate listing for Adaptive Biotechnologies Corporation; the primary context on this page is ADPT:NASDAQ.
A2PLR5:LS
DE · EUR
Alternate listing for Adaptive Biotechnologies Corporation; the primary context on this page is ADPT:NASDAQ.
1HM:TRADEGATE
DE · EUR
Alternate listing for Adaptive Biotechnologies Corporation; the primary context on this page is ADPT:NASDAQ.
ADPT:BOATS
US · USD
Alternate listing for Adaptive Biotechnologies Corporation; the primary context on this page is ADPT:NASDAQ.
1HM:DUS
DE · EUR
Alternate listing for Adaptive Biotechnologies Corporation; the primary context on this page is ADPT:NASDAQ.
1HM:FWB
DE · EUR
Alternate listing for Adaptive Biotechnologies Corporation; the primary context on this page is ADPT:NASDAQ.
1HM:HAM
DE · EUR
Alternate listing for Adaptive Biotechnologies Corporation; the primary context on this page is ADPT:NASDAQ.
1HM:MUN
DE · EUR
Alternate listing for Adaptive Biotechnologies Corporation; the primary context on this page is ADPT:NASDAQ.
1HM:SWB
DE · EUR
Alternate listing for Adaptive Biotechnologies Corporation; the primary context on this page is ADPT:NASDAQ.